BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lekbua A, Ouahed J, O'Connell AE, Kahn SA, Goldsmith JD, Imamura T, Duncan CN, Kelsen JR, Worthey E, Snapper SB, Softic S. Risk-factors Associated With Poor Outcomes in VEO-IBD Secondary to XIAP Deficiency: A Case Report and Literature Review. J Pediatr Gastroenterol Nutr 2019;69:e13-8. [PMID: 31232887 DOI: 10.1097/MPG.0000000000002297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Dowdell AS, Colgan SP. Metabolic Host-Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD). Pharmaceuticals (Basel) 2021;14:708. [PMID: 34451805 DOI: 10.3390/ph14080708] [Reference Citation Analysis]
2 Speir M, Djajawi TM, Conos SA, Tye H, Lawlor KE. Targeting RIP Kinases in Chronic Inflammatory Disease. Biomolecules 2021;11:646. [PMID: 33924766 DOI: 10.3390/biom11050646] [Reference Citation Analysis]
3 Levine AE, Zheng HB, Suskind DL. Linking Genetic Diagnosis to Therapeutic Approach in Very Early Onset Inflammatory Bowel Disease: Pharmacologic Considerations. Pediatr Drugs. [DOI: 10.1007/s40272-022-00503-4] [Reference Citation Analysis]
4 Kuypers FA. Hyperinflammation, apoptosis, and organ damage. Exp Biol Med (Maywood) 2022;:15353702221090454. [PMID: 35475359 DOI: 10.1177/15353702221090454] [Reference Citation Analysis]
5 Tang J, Zhou X, Wang L, Hu G, Zheng B, Wang C, Lu Y, Jin Y, Guo H, Liu Z. Eosinophilic colitis in a boy with a novel XIAP mutation: a case report. BMC Pediatr 2020;20:171. [PMID: 32305064 DOI: 10.1186/s12887-020-02075-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mudde ACA, Booth C, Marsh RA. Evolution of Our Understanding of XIAP Deficiency. Front Pediatr 2021;9:660520. [PMID: 34222142 DOI: 10.3389/fped.2021.660520] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Nambu R, Muise AM. Advanced Understanding of Monogenic Inflammatory Bowel Disease. Front Pediatr 2020;8:618918. [PMID: 33553075 DOI: 10.3389/fped.2020.618918] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Li Q, Zhang H, Dai S. New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease. Front Pediatr 2022;10:714054. [DOI: 10.3389/fped.2022.714054] [Reference Citation Analysis]
9 El-Sayed ZA, Radwan N. Newborn Screening for Primary Immunodeficiencies: The Gaps, Challenges, and Outlook for Developing Countries. Front Immunol 2019;10:2987. [PMID: 32082296 DOI: 10.3389/fimmu.2019.02987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]